Year |
Citation |
Score |
2021 |
Bi Y, Liu J, Li F, Yu J, Bhattaram A, Bewernitz M, Li RJ, Ahn J, Earp J, Ma L, Zhuang L, Yang Y, Zhang X, Zhu H, Wang Y. Model-Informed Drug Development in Pediatric Dose Selection. Journal of Clinical Pharmacology. 61: S60-S69. PMID 34185906 DOI: 10.1002/jcph.1848 |
0.42 |
|
2020 |
Narayan P, Prowell TM, Gao JJ, Fernandes LL, Li E, Jiang X, Qiu J, Fan J, Song P, Yu J, Zhang X, King-Kallimanis BL, Chen W, Ricks TK, Gong Y, et al. FDA Approval Summary: Alpelisib plus fulvestrant for patients with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33168657 DOI: 10.1158/1078-0432.CCR-20-3652 |
0.348 |
|
2020 |
Shah M, Wedam S, Cheng J, Fiero MH, Xia H, Li F, Fan J, Zhang X, Yu J, Song P, Chen W, Ricks TK, Chen XH, Goldberg KB, Gong Y, et al. FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33055172 DOI: 10.1158/1078-0432.CCR-20-2701 |
0.375 |
|
2019 |
Bi Y, Liu J, Li L, Yu J, Bhattaram A, Bewernitz M, Li RJ, Liu C, Earp J, Ma L, Zhuang L, Yang Y, Zhang X, Zhu H, Wang Y. Role of Model-Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling. Journal of Clinical Pharmacology. 59: S104-S111. PMID 31502691 DOI: 10.1002/jcph.1478 |
0.42 |
|
2018 |
Singh H, Walker AJ, Amiri-Kordestani L, Cheng J, Tang S, Balcazar P, Barnett-Ringgold K, Palmby TR, Cao X, Zheng N, Liu Q, Yu J, Pierce WF, Daniels SR, Sridhara R, et al. U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29523624 DOI: 10.1158/1078-0432.CCR-17-3628 |
0.363 |
|
2014 |
Min KA, Zhang X, Yu JY, Rosania GR. Computational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levels. Biopharmaceutics & Drug Disposition. 35: 15-32. PMID 24218242 DOI: 10.1002/Bdd.1879 |
0.664 |
|
2013 |
Min KA, Talattof A, Tsume Y, Stringer KA, Yu JY, Lim DH, Rosania GR. The extracellular microenvironment explains variations in passive drug transport across different airway epithelial cell types. Pharmaceutical Research. 30: 2118-32. PMID 23708857 DOI: 10.1007/S11095-013-1069-5 |
0.66 |
|
2012 |
Yu JY, Zheng N, Mane G, Min KA, Hinestroza JP, Zhu H, Stringer KA, Rosania GR. A cell-based computational modeling approach for developing site-directed molecular probes. Plos Computational Biology. 8: e1002378. PMID 22383866 DOI: 10.1371/Journal.Pcbi.1002378 |
0.665 |
|
2010 |
Yu JY, Rosania GR. Cell-based multiscale computational modeling of small molecule absorption and retention in the lungs. Pharmaceutical Research. 27: 457-67. PMID 20099073 DOI: 10.1007/S11095-009-0034-9 |
0.623 |
|
Show low-probability matches. |